Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract

Technology appraisal guidance
Reference number: TA272
Published: 23 January 2013

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - appeal received

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - appeal received

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - appeal received
23 January 2013
(425.51 Kb 3 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 21 January 2013